SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001615219-23-000034
Filing Date
2023-05-01
Accepted
2023-05-01 08:02:38
Documents
7
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 DEF 14A slrx-2022proxystatement.htm DEF 14A 558958
2 image1a.jpg GRAPHIC 16559
3 image2a.jpg GRAPHIC 90071
4 image3a.jpg GRAPHIC 146109
5 image_0a.jpg GRAPHIC 15020
6 image_1a.jpg GRAPHIC 43236
7 imagea.jpg GRAPHIC 18337
  Complete submission text file 0001615219-23-000034.txt   1014358
Mailing Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021 346-772-0346
Salarius Pharmaceuticals, Inc. (Filer) CIK: 0001615219 (see all company filings)

IRS No.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36812 | Film No.: 23870108
SIC: 2834 Pharmaceutical Preparations